CN101848907A - 具有大麻素-cb1拮抗作用和乙酰胆碱酯酶抑制作用的组合的化合物 - Google Patents

具有大麻素-cb1拮抗作用和乙酰胆碱酯酶抑制作用的组合的化合物 Download PDF

Info

Publication number
CN101848907A
CN101848907A CN200780047166A CN200780047166A CN101848907A CN 101848907 A CN101848907 A CN 101848907A CN 200780047166 A CN200780047166 A CN 200780047166A CN 200780047166 A CN200780047166 A CN 200780047166A CN 101848907 A CN101848907 A CN 101848907A
Authority
CN
China
Prior art keywords
disease
compound
formula
compounds
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200780047166A
Other languages
English (en)
Chinese (zh)
Inventor
J·H·M·兰格
Cg·克鲁泽
B·沙迪德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Priority claimed from PCT/EP2007/064169 external-priority patent/WO2008074816A1/en
Publication of CN101848907A publication Critical patent/CN101848907A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN200780047166A 2006-12-20 2007-12-19 具有大麻素-cb1拮抗作用和乙酰胆碱酯酶抑制作用的组合的化合物 Pending CN101848907A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06126584.9 2006-12-20
EP06126584 2006-12-20
PCT/EP2007/064169 WO2008074816A1 (en) 2006-12-20 2007-12-19 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition

Publications (1)

Publication Number Publication Date
CN101848907A true CN101848907A (zh) 2010-09-29

Family

ID=38024247

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780047166A Pending CN101848907A (zh) 2006-12-20 2007-12-19 具有大麻素-cb1拮抗作用和乙酰胆碱酯酶抑制作用的组合的化合物

Country Status (7)

Country Link
CN (1) CN101848907A (https=)
AR (1) AR064379A1 (https=)
BR (1) BRPI0721060A2 (https=)
IN (1) IN2009CN03566A (https=)
MX (1) MX2009006889A (https=)
TW (1) TW200843772A (https=)
ZA (1) ZA200903779B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113880899A (zh) * 2020-10-30 2022-01-04 杭州拉林智能科技有限公司 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用
CN116033836A (zh) * 2020-07-14 2023-04-28 利斯库生物科学有限公司 包含意外片球菌或来源于其的细胞外囊泡作为有效成分的用于治疗脑部疾病的组合物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116033836A (zh) * 2020-07-14 2023-04-28 利斯库生物科学有限公司 包含意外片球菌或来源于其的细胞外囊泡作为有效成分的用于治疗脑部疾病的组合物
CN113880899A (zh) * 2020-10-30 2022-01-04 杭州拉林智能科技有限公司 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用
WO2022089598A1 (zh) * 2020-10-30 2022-05-05 杭州拉林智能科技有限公司 黄酮苷-有机胺类神经激动剂复盐化合物及其制备方法和应用

Also Published As

Publication number Publication date
TW200843772A (en) 2008-11-16
AR064379A1 (es) 2009-04-01
ZA200903779B (en) 2010-04-28
IN2009CN03566A (https=) 2015-08-07
BRPI0721060A2 (pt) 2014-02-25
MX2009006889A (es) 2009-07-07

Similar Documents

Publication Publication Date Title
RU2451015C2 (ru) Производные 1,2,4-триазола в качестве ингибиторов сигма рецептора
EP2091939B1 (en) Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
KR101738866B1 (ko) 안드로겐 수용체 길항제, 항암제로서 사이클릭 n,n'-다이아릴티오우레아 및 n,n'-다이아릴우레아, 이의 제조방법 및 이의 용도
US20080214559A1 (en) Compounds with a combination of cannabinoid cb1 antagonism and serotonin reuptake inhibition
TW200845963A (en) Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
EP1966146B1 (en) 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
CN101848907A (zh) 具有大麻素-cb1拮抗作用和乙酰胆碱酯酶抑制作用的组合的化合物
EP1603899B1 (en) Heterocyclic urea derivatives for the treatment of pain
US8063062B2 (en) Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
US20110053983A1 (en) (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity
TW200401642A (en) Quinazoline derivatives
KR20090103932A (ko) 카나비노이드-ｃｂ1 길항작용과 세로토닌 재흡수 억제가 조합된 화합물
KR20030036834A (ko) 5-페닐벤질아민 화합물, 그의 제법 및 그의 합성 중간체
HK1143587A (en) Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
US20110172274A1 (en) Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity
US20080312276A1 (en) 4,5 Dihydro-(1H)-Pyrazole Derivatives as Cannabinoid CB1 Receptor Modulators
AU2008263915A1 (en) 4,5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TW200916442A (en) 4, 5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1receptor modulators
HK1143362A (en) Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
CN101454291A (zh) 作为选择性大麻素cb1受体拮抗剂的含硫的吡唑衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1143587

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100929

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1143587

Country of ref document: HK